Zhouliang Wu

4PUBLICATIONS
30CO-AUTHORS
Medical devicesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 26, 2026
Cost-Effectiveness of Circulating Tumor DNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer Based on IMvigor011 Trial.

Zihan Xue, Yunkai Qie, Shan Liang

|Dec 25, 2025
Urinary Tumor DNA to Identify Candidates for Repeat Transurethral Resection in Non-Muscle-Invasive Bladder Cancer.

Zihan Xue, Yunkai Qie, Chong Shen

|Jan 08, 2025
Phase II Pilot Trial of Tislelizumab plus Low-Dose Nab-Paclitaxel for Extensive Very High-Risk Non-Muscle-Invasive Bladder Cancer.

Yunkai Qie, Shiwang Huang, Chong Shen

|Aug 13, 2024
Targeted Inhibition of Lymphovascular Invasion Formation with CREKA Peptide-Modified Silicasomes to Boost Chemotherapy in Bladder Cancer.

Zhouliang Wu, Bozhao Li, Yunkai Qie

Pageof 1

Frequent Collaborators

3 joint publications

Hailong Hu

2 joint publications

Yunkai Qie

2 joint publications

Chong Shen

2 joint publications

Zihan Xue